Piers John Morgan
Director/Board Member chez Pathway Biotech Ltd.
Profil
Piers John Morgan founded uniQure NV in 2009, where he worked as Chief Financial Officer from 2009 to 2014.
Mr. Morgan also currently works at European Biopharmaceutical Enterprises, as Vice Chairman-Innovation & Funding Models, Pathway Biotech Ltd., as Director, Ikarovec Ltd., as Non-Executive Director, and Institute of Chartered Accountants in England & Wales, as Member.
Mr. Morgan also formerly worked at C4X Discovery Ltd., as Chief Executive Officer & Director, C4X Discovery Holdings Plc, as Chief Executive Officer & Director from 2014 to 2015, Trino Therapeutics Ltd., as Non-Executive Chairman from 2012 to 2013, Pharnext SA, as Independent Non-Executive Director from 2021 to 2022, Quethera Ltd., as Non-Executive Director, Close Brothers Group Plc, as Principal, Phytopharm Plc, as Chief Financial Officer from 2007 to 2008, Arrow Therapeutics Ltd., as Chief Financial Officer, Valerio Therapeutics SA, as Chief Operating & Financial Officer from 2005 to 2012, Verona Pharma Plc, as Chief Financial Officer from 2016 to 2020, Amsterdam Molecular Therapeutics (AMT) Holding NV, as Chief Financial Officer & Vice President from 2012 to 2013, Compass Pathways Plc, as Chief Financial Officer, and Ernst & Young Corp.
Finance LLC.
Mr. Morgan received his graduate degree from the University of Cambridge.
Postes actifs de Piers John Morgan
| Sociétés | Poste | Début |
|---|---|---|
European Biopharmaceutical Enterprises
 European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Corporate Officer/Principal | - |
| Pathway Biotech Ltd. | Director/Board Member | - |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Corporate Officer/Principal | - |
Ikarovec Ltd.
 Ikarovec Ltd. Medical/Nursing ServicesHealth Services Ikarovec Ltd. provides human health care services. The company is headquartered in Canterbury, the United Kingdom. | Director/Board Member | - |
Anciens postes connus de Piers John Morgan
| Sociétés | Poste | Fin |
|---|---|---|
| PHARNEXT SCA | Director/Board Member | 16/06/2022 |
| COMPASS PATHWAYS PLC | Director of Finance/CFO | 31/12/2021 |
| VERONA PHARMA PLC | Director of Finance/CFO | 28/02/2020 |
| C4X DISCOVERY HOLDINGS PLC | Chief Executive Officer | 19/11/2015 |
| UNIQURE N.V. | Founder | 20/05/2014 |
Formation de Piers John Morgan
| University of Cambridge | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| CLOSE BROTHERS GROUP PLC | Finance |
| VALERIO THERAPEUTICS | Health Technology |
| VERONA PHARMA PLC | Health Technology |
| PHARNEXT SCA | Health Technology |
| UNIQURE N.V. | Health Technology |
| C4X DISCOVERY HOLDINGS PLC | Health Technology |
| COMPASS PATHWAYS PLC | Health Technology |
| Entreprise privées | 10 |
|---|---|
Phytopharm Plc
 Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | Health Technology |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Commercial Services |
Arrow Therapeutics Ltd.
 Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Amsterdam Molecular Therapeutics (AMT) Holding NV
 Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Commercial Services |
European Biopharmaceutical Enterprises
European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Health Technology |
C4X Discovery Ltd.
 C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Trino Therapeutics Ltd.
 Trino Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Trino Therapeutics Ltd. operates as a drug discovery and development company. It focuses on developing oral small molecules for the treatment and unmet management of inflammatory bowel disease and other inflammatory indications. The company was founded by Neil Howard Frankish and Helen Sheridan in 1999 and is headquartered in Dublin, Ireland. | Health Technology |
| Pathway Biotech Ltd. | |
Quethera Ltd.
 Quethera Ltd. BiotechnologyHealth Technology Quethera Ltd. develops treatment for eye diseases. It focuses on developing therapies to reduce progressive visual loss in glaucoma and other conditions affecting the optic nerve. The company was founded by Peter Stuart Widdowson and Keith Robert Graham Martin in 2013 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Ikarovec Ltd.
Ikarovec Ltd. Medical/Nursing ServicesHealth Services Ikarovec Ltd. provides human health care services. The company is headquartered in Canterbury, the United Kingdom. | Health Services |
